ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0434

Sex Based Differences in Cardiovascular Conditions Associated with Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Analysis of the National Inpatient Sample

Krishna bashyal, Nischit Baral, Calvin Ghimire, Shravya Balmuri, Arvind Kunadi and Sandip Karki, McLaren Flint, Grand Blanc, MI

Meeting: ACR Convergence 2022

Keywords: ANCA associated vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – ANCA-Associated Poster I: Epidemiology, Outcomes, and Classification

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Anti-neutrophil cytoplasmic antibody( ANCA)-associated vasculitis, characterized by inflammation of small and medium sized blood vessels includes three main conditions – eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis and microscopic polyangiitis. Due to the chronic inflammation associated with the disease process as well as use of cytotoxic drugs, it may be associated with potential cardiovascular complications. The aim of our study is to evaluate the cardiovascular conditions in patients with ANCA-associated vasculitis along with sex based differences in cardiovascular conditions.

Methods: All patients were included who were diagnosed with ANCA-associated vasculitis between January 1, 2016 and December 31, 2019 with age more or equal to 18 years in the National Inpatient Sample, the largest all-payer public database of hospital care data in the United States using ICD 10 diagnosis codes. Associated demographics, comorbidities, and hospital complications were extracted from the hospitalization record and reported descriptively. Fisher’s exact test compared sex-specific differences in cardiovascular complications.

Results: From 2016 to 2019, among a total of 28,48,4087 hospitalizations (unweighted sample), 12,306 admissions (45.2 % male, mean age 62.4 ± 16.5 years) included ANCA-associated vasculitis. Among ANCA-associated vasculitis hospitalizations, racial distributions were White 74.5% , Black 7.9% , Hispanic 11.6%, and Asian 2.4%. 517 patients (4.2%) died in the hospital; mean length of stay (LOS) was 7.2 days. The most common comorbid cardiovascular diagnosis was atrial fibrillation (n=2614; 21.2%). Among ANCA vasculitis, 0.2% (n=22) had takotsubo cardiomyopathy, 2.1% (n=252) had pulmonary edema, 8.5% (n=1049) had acute decompensated heart failure, 2.2% (n=269) had supraventricular tachycardia, 1.9% (n=236) had ventricular tachycardia, 0.3% (n=33) had ventricular fibrillation, 2% (n=252) had pericardial disease (including acute or chronic pericarditis or tamponade), 1.3% (n=155) required pressors, and 2.3% (n=281) had disseminated intravascular coagulation. Among ANCA vasculitis, compared to males, females were younger in age (mean age: 62 vs. 63 years; p=0.011), had lower prevalence of atrial fibrillation (17.4% vs 25.9%, p< 0.001), congestive heart failure (24.2 % vs 30.8%, p< 0.001), ischemic heart disease (6.3% vs 11.7%, p< 0.001), peripheral vascular disease (5.7% vs 9.5%, p< 0.001), acute decompensated heart failure (7.4% vs 10%, p< 0.001), pericardial effusion ( 1.6% vs 2.1%, p=0.049), ventricular tachycardia (1.3% vs 2.6%, p< 0.001), ventricular fibrillation (0.2% vs 0.4%, p=0.014), and higher prevalence of takotsubo cardiomyopathy (0.3% vs 0.1%, p=0.01), had lower in-hospital mortality (3.8% vs 4.7%, p=0.010) and shorter length of stay (7 days vs 7.4 days, p=0.019).

Conclusion: Among ANCA-vasculitis hospitalizations, atrial fibrillation is the most common cardiovascular condition and females had fewer cardiovascular complications, lower in-hospital mortality and shorter length of stay compared to males.

Supporting image 1

Supporting image 2


Disclosures: K. bashyal, None; N. Baral, None; C. Ghimire, None; S. Balmuri, None; A. Kunadi, None; S. Karki, None.

To cite this abstract in AMA style:

bashyal K, Baral N, Ghimire C, Balmuri S, Kunadi A, Karki S. Sex Based Differences in Cardiovascular Conditions Associated with Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Analysis of the National Inpatient Sample [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/sex-based-differences-in-cardiovascular-conditions-associated-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-a-retrospective-analysis-of-the-national-inpatient-sample/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-based-differences-in-cardiovascular-conditions-associated-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-a-retrospective-analysis-of-the-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology